scholarly journals KUALITAS HIDUP PASIEN KANKER PAYUDARA DI RSUP DR. KARIADI SEMARANG MENGGUNAKAN KUISIONER EORTC QLQ-C30

2021 ◽  
Vol 18 (01) ◽  
pp. 16
Author(s):  
Marwin Marwin ◽  
Dyah Aryani Perwitasari ◽  
Susan Fitri Candradewi ◽  
Bayu Prio Septiantoro ◽  
Fredrick Dermawan Purba

ABSTRACT Breast cancer is the most common cancer found in women and is the dominant cancer in Indonesia. Cancer treatments such as chemotherapy can affect the quality of life of patients including physical, psychological, and social. The purpose of this study is to measure the quality of life of breast cancer patients. This research used cross sectional study design. The patient quality of life was measured using the EORTC QLQ-C30 questionnaire. The subjects of this study were breast cancer patients in RSUP Dr. Kariadi Semarang meeting the inclusion criteria. The cognitive function domain, social function, emotional function, role function, and physical function were 86,15 ± 17,82; 84,10 ± 21,13; 82,56 ± 17,72; 77,95 ± 29,77; 76,72 ± 22,95, respectively. Whereas in symptom scale group from pain, fatigue, insomnia, appetite loss, financial difficulties, nausea and vomiting, constipation, dyspnea and diarrhea were 32,82 ± 30,33; 32,65 ± 21,14; 31,79 ± 34,58; 31,79 ± 32,51; 30,77 ± 32,44; 23,59 ± 25,67; 17,95 ± 30,9; 4,62 ± 14,28; 4,10 ± 13,83, respectively. For global health status / quality of life obtained 72.18 ± 18.94. The highest score on the functional scale is the cognitive function domain and the lowest score is the physical function.On the scale of symptom the domain that has the highest score is the pain domain and the lowest score is the diarrhea domain. Keywords: quality of life, breast cancer, EORTC QLQ-C30

2014 ◽  
Vol 1 (1) ◽  
pp. 22 ◽  
Author(s):  
TanMay Leng ◽  
SeowGek Ching ◽  
DahlianaBinte Idris ◽  
TeoLee Wah ◽  
LohSoon Yue ◽  
...  

2019 ◽  
Vol 17 (1) ◽  
Author(s):  
Diriba Alemayehu Gadisa ◽  
Esayas Tadesse Gebremariam ◽  
Getnet Yimer Ali

Abstract Background Breast cancer is the most common cancer among women and it affects quality of life of those women. So far, the two most frequently used tools for assessing health related quality of life in breast cancer patients, EORTC QLQ-C30 and EORTC QLQ-BR23 modules, were not validated in Ethiopia. Hence, the present study aimed to assess the psychometric properties of the tools among Ethiopian breast cancer patients. Methods Institutional based longitudinal study was conducted from January 1 to May 1, 2017 GC at only nationwide oncology center, Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia. A total of 146 patients who visited the facility during that period, with no missing quality of life data, were selected for analysis. The psychometric properties of the EORTC QLQ-C30 and EORTC QLQ-BR23 were evaluated in terms of reliability, convergent, divergent, construct and clinical validity using SPSS version 22. Results Satisfactory internal consistency reliability (Cronbach’s α coefficients > 0.7) was confirmed, except for cognitive function (α = 0.516) of EORTC QLQ-C30 and body image (α = 0.510) of EORTC QLQ-BR23. Multiple-trait scaling analysis demonstrated a good convergent and divergent validity. No scaling errors were observed. Most items in EORTC QLQ-BR23 possessed a weak or no correlation with its own dimension in EORTC QLQ-C30 (r < 0.4) except with some of symptom scales. A statistically significant chemotherapy induced quality of life scores changes (P ≤ 0.05) were observed in all dimensions of both instruments between baseline and the end of first cycle chemotherapy, except for body image (P = 0.985) and sexual enjoyment (P = 0.817) of EORTC QLQ-BR23, indicating clinical validity. Conclusion Amharic version of the EORTC QLQ-C30 and EORTC QLQ-BR23 modules are valid and adequately reliable tool and can be used for clinical and epidemiological cancer researches to study the health related quality of life (HRQoL) of women with breast cancer in Ethiopia.


2020 ◽  
Vol 11 (3) ◽  
pp. 3813-3818
Author(s):  
Thenmozhi P ◽  
Simeon I

Quality of life is a significant part of patient care among cancer patients. Toxicities and adverse impacts of chemotherapy influence personal satisfaction in disease patients, and it likewise makes challenges in satisfying family and social jobs. Hence the study aimed to assess the quality of life of cancer patients receiving chemotherapy. Cross-sectional research design was employed with 50 samples which matched the inclusion criteria were selected by convenience sampling technique. Demographic variables data were collected by using a structured questionnaire followed by assessing the quality of life by using the EORTC QLQ-C30 questionnaire. The findings of the study revealed the highest median value in the cognitive functioning, social functioning, role functioning and also in physical functioning compared symptom scale and in which the lowest score in the symptoms of nausea & vomiting, loss of craving, fatigue, diarrhea and constipation and face many challenges related to finance. Based on findings, further studies can be conducted to correlate the quality of life with clinical assessment and focus on the mind-body exercise such as yoga, meditation and physical therapy like exercise, massage to enhance the quality of life and to complete the entire cycle of chemotherapy.


2020 ◽  
Vol 20 (3) ◽  
pp. 990
Author(s):  
Debbie Nomiko

Breast cancer is a disease that occurs due to excessive growth or uncontrolled development of cells or breast tissue. Quality of life is an important goal in the treatment of cancer, and concerns about physical, psychological, body image disorders. The purpose of this study is to find out the factors related to the quality of life of breast cancer patients at Raden Mattaher Jambi Hospital in 2019. Research uses a coelative descriptive research design with a cross sectional approach. The research population is breast cancer patients who are treating at Raden Mattaher Jambi Hospital. Sampling is done on a sampling quota. Data collection instruments use the respondent's characteristic data questionnaire, coping mechanism, and quality of life questionnaire using the EORTC-QLQ 30 format. The data was analyzed univariate and bivariate with the Kai-Squared test (CI 95%). The results of the study obtained the average age of respondents was 51.8 years, the majority were elementary and high school educated with a proportion of 35.7%, and most did not work as many as 35 people (62.5%). The results of bivariate analysis that there is a relationship between the length of the cancer and the mechanism of coffee and the quality of life of breast cancer patients in Raden Mattaher Jambi Hospital. It is hoped that hospitals can facilitate the interaction activities of cancer patients through the formation of groups for cancer patients so that they can share experiences and information in terms of improving quality of life. For nursing research, it is hoped that this research can be the basic data in carrying out the next research.


2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Engida Abebe ◽  
Kassaw Demilie ◽  
Befekadu Lemmu ◽  
Kirubel Abebe

Background. Mastectomy is the most common form of treatment for a developing-nation woman diagnosed with breast cancer. This can have huge effect on a women’s quality of life. Objective. To assess mastectomy-related quality of life in female breast cancer patients. Materials and Methods. A facility-based cross-sectional descriptive study was conducted from February 1st to July 30th, 2018. A pretested structured data collection format was used to interview patients. The European Organization for Research and Treatment for Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and Breast Cancer-Specific (EORTC QLQ-BR23) were used to evaluate quality of life, functional capacity, and symptom scales. Data was analyzed with SPSS version 23. Results. The mean age of the 86 patients was 43.2 years (SD±11.4) and ranged from 25 to 70 years. 54.7% (47) of patient’s mastectomy was done on the right side. Based on EORTC QLQ-C30 global health status/QOL scale, the mean score was 48.3. On the evaluation of EORTC QLQ-BR23, future perspective about their health was low with a mean of 40.3 and their sexual functioning and enjoyment were significantly affected with mean scores of 85.3 and 71.2, respectively. Symptom scales were low with mean from 19.1 to 24.5. Majority (49, 57%) of respondents do not want to have breast reconstruction after mastectomy. Conclusion. Our breast cancer patients who underwent mastectomy performed poor in terms of quality of life as compared to international findings which demands attention in incorporating psychosocial aspects in the treatment plan.


Author(s):  
Lucia Keilmann ◽  
Lina Matthies ◽  
Elisabeth Simoes ◽  
Andreas D. Hartkopf ◽  
Alexander N. Sokolov ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-12 ◽  
Author(s):  
Qing Chen ◽  
Shunping Li ◽  
Min Wang ◽  
Liu Liu ◽  
Gang Chen

Objectives. Breast cancer is one of the major cancers in Chinese women. European Organization for Research and Treatment of Cancer Quality of Life Questionnaires (EORTC QLQ-C30 and QLQ-BR23) are now the most common and well developed instruments assessing the health-related quality of life (HRQOL) of breast cancer patients internationally, whereas there are relatively few Chinese studies. This study has two aims: to investigate the HRQOL and explore which dimensions of HRQOL play more important roles in breast cancer patients’ overall quality of life in China and to explore the latent factor structure and the potential complementary relationship between these two EORTC questionnaires. Methods. This cross-sectional and descriptive study was performed from October 2014 to February 2015 in Qingdao Municipal Hospital, China. A total of 621 women breast cancer patients were enrolled. EOTRC QLQ-C30 and QLQ-BR23 were used to evaluate the HRQOL of the participants. The nonparametric test, multiple linear regression, and exploratory factor analysis (EFA) were the main statistical methods we used. Results. 608 participants completed the questionnaires with a response rate of 97.9%. The mean age of the participants was 48.0 years (SD=9.6). About 33% were illiterate or only finished primary school education. Almost half participants (47.4%) only adopted chemotherapy. HRQOL was significantly different with regard to patients’ social-demographic and clinical characteristics. Age, residence, educational level, employment status, and TNM stage were five significant predictors for global health status. Pain, dyspnea, sexual enjoyment, and systemic therapy side-effect were main subscales which had a significant impact on the global health status for patients in different TNM stage. The EFA result suggested that QLQ-C30 and QLQ-BR23 were complementary questionnaires. Conclusions. The EORTC QLQ-C30 and QLQ-BR23 questionnaires provide complementary information regarding breast cancer patients’ HRQOL, and depending on the different cancer staging functional/symptom scales which significantly contributed to the overall HRQOL differed.


2018 ◽  
Vol 29 ◽  
pp. viii59-viii60 ◽  
Author(s):  
V. Bjelic-Radisic ◽  
A. Bottomley ◽  
F. Cardoso ◽  
D. Cameron ◽  
E. Brain ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document